Vaxart to Hold Q1 2024 Update and Financial Results Call on May 13

Vaxart, Inc. (NASDAQ: VXRT), based in South San Francisco, California, announced it will release its financial results for the first quarter ending March 31, 2024, after the market closes on Monday, May 13, 2024. On the same day, the senior management team will provide a business update during a conference call scheduled to begin at 4:30 p.m. ET.

The conference call can be accessed by dialing (877) 407-0832 for domestic participants and (201) 689-8433 for international participants. The Conference ID for the call is 13745591. Additionally, a live webcast of the conference call will be available. Investors are encouraged to submit their questions in writing ahead of the conference call to ir@vaxart.com. A replay of the webcast will be available on Vaxart's website after the event concludes.

Vaxart is a clinical-stage biotechnology company that focuses on developing oral recombinant vaccines using its proprietary delivery platform. These vaccines are designed to be administered in pill form, which allows for storage and transportation without the need for refrigeration, mitigating the risks associated with needle-stick injuries. Vaxart believes its pill vaccine delivery system is well-suited for creating recombinant vaccines for both existing and new indications.

The company's current development programs include oral vaccines to guard against coronavirus, norovirus, and influenza, in addition to a therapeutic vaccine for human papillomavirus (HPV). This HPV vaccine is Vaxart’s first foray into immune-oncology. The company has submitted broad patent applications in both domestic and international markets to cover its proprietary technology, which includes methods for oral vaccination using adenovirus vectors and TLR3 agonists.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!